• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

HHS Unveils AI Strategic Plan for Healthcare, Human Services and Public Health

by Fred Pennic 01/10/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– The U.S. Department of Health and Human Services (HHS) today has released its Artificial Intelligence (AI) Strategic Plan, outlining a comprehensive vision for how AI can transform healthcare, human services, and public health. 

– The HHS AI Strategic Plan serves as a call to action for the healthcare industry, encouraging stakeholders to embrace AI’s potential while prioritizing ethical considerations and equitable access. 

HHS AI Strategic Plan Key Goals

The HHS AI Strategic Plan centers around four key goals:

  1. Catalyzing AI Innovation: Fostering the development and adoption of AI to improve people’s lives.
  2. Promoting Trustworthy AI: Ensuring AI is developed and used ethically and responsibly.
  3. Democratizing AI: Promoting access to AI technologies and resources.
  4. Cultivating AI-Ready Workforces: Developing workforces capable of effectively and safely using AI.

A Roadmap for AI in Health and Human Services

The plan provides a detailed roadmap for integrating AI across various HHS domains, including:

  • Medical Research and Discovery: Accelerating research and development of new treatments and cures.
  • Medical Product Development: Enhancing the safety and effectiveness of drugs, biologics, and medical devices.
  • Healthcare Delivery: Improving clinical outcomes, patient safety, and efficiency.
  • Human Services: Enhancing the delivery of social services and support to individuals and families.
  • Public Health: Strengthening public health surveillance, prediction, and response to health threats.

Addressing Opportunities and Risks

The plan acknowledges the transformative potential of AI in healthcare while also addressing potential risks, such as algorithmic bias and data privacy concerns. It emphasizes the importance of responsible AI use, ensuring equitable access, safeguarding protected information, and maintaining human oversight.

Actionable Strategies

To achieve its goals, HHS outlines key actions, including:

  • Expanding AI adoption: Promoting the use of AI across various healthcare settings.
  • Modernizing infrastructure: Investing in infrastructure to support AI development and deployment.
  • Enhancing collaboration: Fostering partnerships to accelerate AI innovation.
  • Setting clear standards: Establishing guidelines for responsible AI use.
  • Increasing access to resources: Providing data, tools, and training to promote wider AI adoption.

For more information, visit https://www.healthit.gov/topic/hhs-ai-strategic-plan

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |